Browsing by Author "Dokmetas, H. S."
Now showing items 1-8 of 8
-
Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly
Karaca, Z.; Tanriverdi, F.; Elbuken, G.; Cakir, I.; Donmez, H.; Selcuklu, A.; Durak, A. C.; Dokmetas, H. S.; Colak, R.; Unluhizarci, K.; Kelestimur, F. (WILEY-BLACKWELL, 2011)Objective The primary aim of the study was to compare the efficacy of Oct-LAR and surgery in terms of controlling IGF-1 and GH levels and tumour volumes. The second aim was to compare two primary treatment modalities in ... -
Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma
Kilicli, F.; Dokmetas, H. S.; Gurelik, M. (SINGAPORE MEDICAL ASSOC, 2010)Pituitary apoplexy occurs as a very rare complication following pituitary function tests. Signs and symptoms are due to the rapid expansion of an infarcted and/or haemorrhagic pituitary adenoma. We report a case of ... -
Effect of Vitamin D Treatment on Serum Sclerostin Level
Acibucu, F.; Dokmetas, H. S.; Acibucu, D. O.; Kilicli, F.; Aydemir, M.; Cakmak, E. (JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH, 2017)Objective Sclerostin is an osteocyte-secreted endogenous inhibitor of Wnt signaling. Several systemic and local factors have been suggested as possible regulators of sclerostin expression by osteocytes. In this study, we ... -
Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from pituitary study group database
Tanriverdi, F.; Dokmetas, H. S.; Kebapci, N.; Kilicli, F.; Atmaca, H.; Yarman, S.; Ertorer, M. E.; Erturk, E.; Bayram, F.; Tugrul, A.; Culha, C.; Cakir, M.; Mert, M.; Aydin, H.; Taskale, M.; Ersoz, N.; Canturk, Z.; Anaforoglu, I.; Ozkaya, M.; Oruk, G.; Hekimsoy, Z.; Kelestimur, F.; Erbas, T. (HUMANA PRESS INC, 2014)Hypopituitarism in adult life is commonly acquired and the main causes are known as pituitary tumors and/or their treatments. Since there are new insights into the etiology of hypopituitarism and presence of differences ... -
Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment
Acibucu, F.; Acibucu, D. O.; Akkar, O. B.; Dokmetas, H. S. (JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH, 2016)Introduction: Radioactive iodine (RAI) ablation treatment is used for patients diagnosed with well-differentiated thyroid cancer in order to reduce the risk of recurrence. RAI ablation treatment can adversely affect gonads ... -
The evaluation of the role of beta-hydroxy fatty acids on chronic inflammation and insulin resistance
Soydan, A. S.; Dokmetas, H. S.; Cetin, M.; Koyuncu, A.; Kaptanoglu, E.; Elden, H. (HINDAWI PUBLISHING CORPORATION, 2006)beta-hydroxy fatty acids are a major component of lipid A moiety of lipopolysaccaride. We aimed to investigate the role of free beta-hydroxy fatty acids on inflammation, as well as to evaluate their e. ects on cytokine ... -
Investigation of pituitary functions in patients with acute meningitis: A pilot study
Tanriverdi, F.; Alp, E.; Demiraslan, H.; Dokmetas, H. S.; Unluhizarci, K.; Doganay, M.; Casanueva, F. F.; Kelestimur, F. (SPRINGER, 2008)Objective: Although long-term pituitary consequences of tuberculous meningitis are well documented in the literature, there have been few case reports of pituitary dysfunction after acute bacteria[ or viral meningitis. In ... -
RESULTS OF GALATA STUDY: GALVUS EFFICACY AND SAFETY ASSESSMENT IN TURKISH POPULATION
Keskin, L.; Dokmetas, H. S.; Akin, F.; Ayvaz, G.; Boz, M.; Canberk, A.; Tasan, E.; Guler, S.; Delibasi, T.; Sahin, M.; Uren, E. (ELSEVIER SCIENCE INC, 2013)…